News
Meet Four Graduate Student Researchers Advancing Cancer Science
The UCSF Helen Diller Family Comprehensive Cancer Center's Molecular Oncology Program (MOP) recently provided Graduate Student Support to four PhD student researchers whose work spans prostate cancer, leukemia, immunotherapy, and targeted drug delivery. The one-year awards provided $25,000 in pilot
A Growing Lab Advances Precision Prostate and Bladder Cancer Therapy
Just three years after launching her laboratory at UCSF, urologic oncologist Carissa Chu, MD, is entering a new phase of growth. This summer, her lab will expand to eleven members, nine of whom are women, marking a milestone as she pursues more personalized treatments for prostate and bladder cancer
UCSF Study: Breast Cancer Is Rising Fast in Asian American Women
A new study led by UC San Francisco has found an alarming rise in invasive breast cancer among Asian American women over the last two decades. Rates are rising among nearly all Asian American ethnic groups much faster than they are in any other U.S. ethnic group; and this is especially true among
Why it Might Be Time to Reassess Your Long-term Prostate Medication
One in three men will experience moderate-to-severe lower urinary tract symptoms in their lifetime, including frequent urination, difficulty starting urination, and a weak urine stream. Although these are common symptoms in older men, they can significantly impact quality of life. The majority of
New Program at UCSF and UC Berkeley Will Drive Advances in Medicine
UC San Francisco and UC Berkeley have launched a joint program to develop the frontier of AI and biomedicine to accelerate advances in clinical care. The Bakar Computational Biomedicine Initiative will bring together world-class faculty expertise in computing, AI, statistics, biology, and medicine
Could These Tiny Organs Save Millions of Lives?
If you’re a woman newly diagnosed with breast cancer, treatment can feel … well, scary. Will chemotherapy work? Or will it become a cycle of educated guesswork: trying one drug combination, waiting, scanning? If the tumor doesn’t respond, trying something else. In the meantime, the cancer doesn’t
FDA Clears Zyn: Will Nicotine Pouches Hook a New Generation?
UC San Francisco researchers say federal regulators have handed the tobacco industry a potent new marketing tool — one that could help the largest nicotine pouch maker lure a new generation of users. The U.S. Food and Drug Administration cleared Philip Morris-owned Zyn on June 30 to claim that using